Early Australian clinical trials in patients with incurable malignant lung mesothelioma have raised new hope for cure.

Cancer  specialists at the Royal Prince Alfred Hospital in Sydney have shown amazing results in patients infused with nanocells containing a type of genetic material called microRNA.
MicroRNA is involved in controlling DNA replication, cell proliferation and cell death.

This trial is around half completed and involves 24 patients and is a phase 1 trial.

One 51 year old patient was given this microRNA and his mesothelioma cancer became almost invisible and his health improved dramatically. This improvement took only 8 weeks and only low doses were required to get the good response!

The microRNA treatment has been branded as “TargomiRs” and was developed by a biotech company called EnGenelC

This is very exciting – so watch this space!

Print Friendly, PDF & Email